Gian Luca Rampioni Vinciguerra

Pubblicazioni

Titolo	Pubblicato in	Anno
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2025
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice	NPJ BREAST CANCER	2024
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma	SIGNAL TRANSDUCTION AND TARGETED THERAPY	2024
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer	EMBO MOLECULAR MEDICINE	2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors	JOURNAL OF PATHOLOGY	2024
Editorial: catch me if you can: cellular plasticity in tumor progression and drug resistance	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY	2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity	SCIENCE ADVANCES	2024
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance	SIGNAL TRANSDUCTION AND TARGETED THERAPY	2023
Clear cell carcinoma of the stomach: a rare tumor variant imparting poor prognosis	ACTA CHIRURGICA BELGICA	2023
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation	CANCER COMMUNICATIONS	2023
A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysis	CELL DEATH AND DIFFERENTIATION	2023
Role of Fra-2 in cancer	CELL DEATH AND DIFFERENTIATION	2023
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review	FRONTIERS IN ONCOLOGY	2022
EMILIN-1 deficiency promotes chronic inflammatory disease through TGFβ signaling alteration and impairment of the gC1q/α4β1 integrin interaction	MATRIX BIOLOGY	2022
Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer	CANCER RESEARCH	2022
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer	JOURNAL OF PATHOLOGY	2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC	EMBO MOLECULAR MEDICINE	2021
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer	CELL DEATH & DISEASE	2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients. Results from the Phase IV MITO16A/ManGO OV-2 Translational Study	CANCERS	2021
Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer	CANCER RESEARCH	2020